Skip to content
TrustList
Yuuwa Capital cover

About Yuuwa Capital

Yuuwa was initially established in 2009 as the manager of a $40 million venture capital fund with investment from the Australian Federal Government's Innovation Investment Fund (IIF) program and private investors.

Yuuwa provides expertise to identify new projects and help founders and management start and scale companies in the life sciences area.

Yuuwa connects specialist early stage investors to high quality early stage ventures in life sciences.

LLB BJuris BCom(Hons) GAICD

Co-founder

Liddy has over 20 years as a founder, investor and management in early stage startups.   Her prior experience includes co-founder of iCeutica Inc group (acquired), Dimerix Limited (ASX listed) and Argus Biomedical Pty Ltd (acquired).  Before working with start-ups Liddy was an Associate Director, Macquarie Bank focusing on mergers and acquisitions.  She has been admitted as a barrister and solicitor in various Australian jurisdictions.  Liddy is involved in all aspects of investing, building and supporting Yuuwa’s portfolio companies.  Liddy serves/has served on the Board of various Yuuwa investee companies including ASX listed AdAlta Limited, Agworld Pty Ltd and Fitgenes Australia Limited. She is a Director of ASX-listed Argenica Ltd (ASX: AGN) and the Ear Science Institute of Australia.

BSc(Hons) PhD MBA GAICD

Co-founder James is an accomplished scientist, entrepreneur and investor He has been involved from concept to commercialisation, including CEO, CTO and Board roles, of numerous biotech companies which have resulted in five FDA approved drugs and devices He conceived the technology behind iCeutica Inc (acquired in 2011) and co-discovered the lead therapy for ASX-listed Dimerix Limited (ASX:DXB), currently in Phase 3 trials for Chronic Kidney Disease

James is involved in all phases of investment across the Yuuwa portfolio, and is currently a Director of PolyActiva Pty Ltd and alternate Director of Adalta Limited (ASX:1AD) He remains Chairman of Dimerix and is on the Board of the Perron Institute for Neurological and Translational Science

©2022 by Yuuwa Proudly created with Wix com

Ask TrustList to introduce you to Yuuwa Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Yuuwa Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Yuuwa Capital.

Yuuwa Capital alternatives

Similar listings buyers compare against this one.